Clinical Trial Update: Low Grade Lymphoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for low-grade lymphoma (indolent lymphoproliferative disorders); the status of the trial is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indolent Lymphoproliferative Disorders

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Indolent Lymphoproliferative Disorders | Phase 4 | Status: UNKNOWN